Neogen (NEOG) Develops New, Faster DON Test
Up)
Neogen Corporation (Nasdaq: NEOG) has developed a new test for deoxynivalenol (DON) that combines the speed and simplicity of a lateral flow test with the fully quantitative precision of a more demanding testing method.
The presence of the mold toxin DON in certain grains is a major concern to producers of animal feed and human food.
Neogen's new Reveal Q+ for DON delivers precise results ranging from 0.3 to 6 parts per million (ppm) of DON after only 3 minutes, following an extraction procedure that only requires water. Reveal Q+ test strips are read in Neogen's AccuScan III lateral flow test reader to deliver exact results.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The presence of the mold toxin DON in certain grains is a major concern to producers of animal feed and human food.
Neogen's new Reveal Q+ for DON delivers precise results ranging from 0.3 to 6 parts per million (ppm) of DON after only 3 minutes, following an extraction procedure that only requires water. Reveal Q+ test strips are read in Neogen's AccuScan III lateral flow test reader to deliver exact results.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
- HeartWare (HTWR) Publishes Encouraging Data from ADVANCE in Advanced Heart Failure
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
